SIVA1 and gastric cancer: The results indicated that inhibition of Siva-1 expression prevented drug efflux in gastric cancer cells, increased the sensitivity of cells to the chemotherapeutic drug VCR, decreased the number and size of cancer cell colonies, and increased the cell apoptosis rate.